Works matching IS 00070920 AND DT 2010 AND VI 103 AND IP 6

Results: 26

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

Published in:

2010

By:

Edwards, S. M.;
Evans, D. G. R.;
Hope, Q.;
Norman, A. R.;
Barbachano, Y.;
Bullock, S.;
Kote-Jarai, Z.;
Meitz, J.;
Falconer, A.;
Osin, P.;
Fisher, C.;
Guy, M.;
Jhavar, S. G.;
Hall, A. L.;
O'Brien, L. T.;
Gehr-Swain, B. N.;
Wilkinson, R. A.;
Forrest, M. S.;
Dearnaley, D. P.;
Ardern-Jones, A. T.

Publication type:

journal article

The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study.

Published in:

2010

By:

Proctor, M. J.;
Talwar, D.;
Balmar, S. M.;
O'Reilly, D. S. J.;
Foulis, A. K.;
Horgan, P. G.;
Morrison, D. S.;
McMillan, D. C.

Publication type:

journal article

Wnt signalling in adenomas of familial adenomatous polyposis patients.

Published in:

2010

By:

Caldwell, G. M.;
Jones, C. E.;
Ashley, A. M.;
Wei, W.;
Hejmadi, R. K.;
Morton, D. G.;
Matthews, G. M.

Publication type:

journal article

Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool.

Published in:

2010

By:

Chia, Y. H.;
Ellis, M. J.;
Ma, C. X.

Publication type:

journal article

Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules.

Published in:

2010

By:

K&;#x00F6;rner, A.;
Mudduluru, G.;
Manegold, C.;
Allgayer, H.;
Körner, A

Publication type:

journal article

Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients.

Published in:

2010

By:

Mailliez, A.;
Baldini, C.;
Van, J. T.;
Servent, V.;
Mallet, Y.;
Bonneterre, J.

Publication type:

journal article

hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.

Published in:

2010

By:

Cocco, E.;
Hu, Z.;
Richter, C. E.;
Bellone, S.;
Casagrande, F.;
Bellone, M.;
Todeschini, P.;
Krikun, G.;
Silasi, D-A.;
Azodi, M.;
Schwartz, P. E.;
Rutherford, T. J.;
Buza, N.;
Pecorelli, S.;
Lockwood, C. J.;
Santin, A. D.

Publication type:

journal article

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.

Published in:

2010

By:

Buffa, F. M.;
Harris, A. L.;
West, C. M.;
Miller, C. J.

Publication type:

Correction Notice

The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer.

Published in:

2010

By:

Lammers, L. A.;
Mathijssen, R. H. J.;
van Gelder, T.;
Bijl, M. J.;
de Graan, A-J. M.;
Seynaeve, C.;
van Fessem, M. A.;
Berns, E. M.;
Vulto, A. G.;
van Schaik, R. H. N.

Publication type:

journal article

Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria.

Published in:

2010

By:

Vassiliou, V.;
Andreopoulos, D.

Publication type:

Letter

Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer.

Published in:

2010

By:

Mori, N.;
Kyo, S.;
Nakamura, M.;
Hashimoto, M.;
Maida, Y.;
Mizumoto, Y.;
Takakura, M.;
Ohno, S.;
Kiyono, T.;
Inoue, M.

Publication type:

journal article

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma.

Published in:

2010

By:

Lee, S.;
Park, Y. H.;
Kim, K. H.;
Cho, E. Y.;
Ahn, Y. C.;
Kim, K.;
Shim, Y-M.;
Ahn, J. S.;
Park, K.;
Im, Y-H.

Publication type:

journal article

Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer.

Published in:

2010

By:

Okugawa, Y.;
Miki, C.;
Toiyama, Y.;
Yasuda, H.;
Yokoe, T.;
Saigusa, S.;
Hiro, J.;
Tanaka, K.;
Inoue, Y.;
Kusunoki, M.

Publication type:

journal article

SV40 associated miRNAs are not detectable in mesotheliomas.

Published in:

2010

By:

Gee, G. V.;
Stanifer, M. L.;
Christensen, B. C.;
Atwood, W. J.;
Ugolini, D.;
Bonassi, S.;
Resnick, M. B.;
Nelson, H. H.;
Marsit, C. J.;
Kelsey, K. T.

Publication type:

journal article

Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma.

Published in:

2010

By:

Pedretti, M.;
Verpelli, C.;
M&;#x00E5;rlind, J.;
Bertani, G.;
Sala, C.;
Neri, D.;
Bello, L.;
Mårlind, J

Publication type:

journal article

Osteopontin is a marker for cancer aggressiveness and patient survival.

Published in:

2010

By:

Weber, G. F.;
Lett, G. S.;
Haubein, N. C.

Publication type:

journal article

Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib.

Published in:

2010

By:

Flaig, T. W.;
Costa, L. J.;
Gustafson, D. L.;
Breaker, K.;
Schultz, M. K.;
Crighton, F.;
Kim, F. J.;
Drabkin, H.

Publication type:

journal article

Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.

Published in:

2010

By:

Campbell, H. E.;
Gray, A. M.;
Harris, A. L.;
Briggs, A. H.;
Taylor, M. A.

Publication type:

journal article

Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England.

Published in:

2010

By:

Howell-Jones, R;
Bailey, A;
Beddows, S;
Sargent, A;
de Silva, N;
Wilson, G;
Anton, J;
Nichols, T;
Soldan, K;
Kitchener, H

Publication type:

Correction Notice

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome.

Published in:

2010

By:

Hassel, J. C.;
Sucker, A.;
Edler, L.;
Kurzen, H.;
Moll, I.;
Stresemann, C.;
Spieth, K.;
Mauch, C.;
Rass, K.;
Dummer, R.;
Schadendorf, D.

Publication type:

journal article

Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria.

Published in:

2010

By:

Hamaoka, T.;
Costelloe, C. M.;
Madewell, J. E.;
Liu, P.;
Hortobagyi, G. N.;
Ueno, N. T.

Publication type:

Letter

miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).

Published in:

2010

By:

Kikkawa, N.;
Hanazawa, T.;
Fujimura, L.;
Nohata, N.;
Suzuki, H.;
Chazono, H.;
Sakurai, D.;
Horiguchi, S.;
Okamoto, Y.;
Seki, N.

Publication type:

journal article

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma.

Published in:

2010

By:

Santoro, A.;
Pressiani, T.;
Citterio, G.;
Rossoni, G.;
Donadoni, G.;
Pozzi, F.;
Rimassa, L.;
Personeni, N.;
Bozzarelli, S.;
Colombi, S.;
De Braud, F. G.;
Caligaris-Cappio, F.;
Lambiase, A.;
Bordignon, C.

Publication type:

journal article

Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression.

Published in:

2010

By:

Elsberger, B.;
Fullerton, R.;
Zino, S.;
Jordan, F.;
Mitchell, T. J.;
Brunton, V. G.;
Mallon, E. A.;
Shiels, P. G.;
Edwards, J.

Publication type:

journal article

Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.

Published in:

2010

By:

Wu, C-F.;
Ng, K-F.;
Chen, C-S.;
Chang, P-L.;
Chuang, C-K.;
Weng, W-H.;
Liao, S-K.;
Pang, S-T.

Publication type:

journal article

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma.

Published in:

2010

By:

Maréchal, R;
Demetter, P;
Nagy, N;
Berton, A;
Decaestecker, C;
Polus, M;
Closset, J;
Devière, J;
Salmon, I;
Van Laethem, J-L

Publication type:

Correction Notice